ORIGINAL RESEARCH
Published on 07 Mar 2025
Rapamycin combined with osimertinib alleviated non-small cell lung cancer by regulating the PARP, Akt/mTOR, and MAPK/ERK signaling pathways
doi 10.3389/fmolb.2025.1548810
- 364 views
- Frontiers in Molecular Biosciences
- Molecular Diagnostics and Therapeutics
- Research Topics
- Exploring and Overcoming Cancer Drug Resistance: Novel Insights and Strategies
Exploring and Overcoming Cancer Drug Resistance: Novel Insights and Strategies
576
Total downloads
2,861
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.